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a  b  s  t  r  a  c  t
The  World  Health  Organization  and  its  partners  are  aiming  to eliminate  trachoma  as  a  public  health
problem  by 2020. In  this  study,  we  compare  forecasts  of TF prevalence  in  2011  for 7 different  statistical  and
mechanistic  models  across  9 de-identiﬁed  trachoma  endemic  districts,  representing  4 unique  trachoma
endemic  countries.  We  forecast  TF prevalence  between  1–6  years  ahead  in time  and compare  the  7
different  models  to  the observed  2011  data  using  a log-likelihood  score.  An  SIS  model,  including  a district-
speciﬁc  random  effect  for  the  district-speciﬁc  transmission  coefﬁcient,  had  the  highest  log-likelihood
score  across  all 9 districts  and  was  therefore  the  best  performing  model.  While  overall  the deterministic
transmission  model  was  the  least  well  performing  model,  although  it did  comparably  well  to  the  other
models  for  8 of  9 districts.  We  perform  a  statistically  rigorous  comparison  of the forecasting  ability  of  a
range  of  mathematical  and  statistical  models  across  multiple  endemic  districts  between  1  and  6  years
ahead  of the  last  collected  TF prevalence  data  point  in  2011,  assessing  results  against  surveillance  data.
This study  is a step  towards  making  statements  about  likelihood  and  time  to elimination  with regard  to
the WHO  GET2020  goals.
©  2017  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Trachoma remains the world’s leading infectious cause of blind-
ness (Anon, 2012; Mariotti et al., 2009), and it is currently estimated
that 200 million individuals are living at risk of blindness from tra-
choma (World Health Organization, 2016). WHO  and its partners
are aiming to eliminate trachoma as a public health concern by
2020. To help achieve this, WHO  endorses the SAFE strategy. This
four pronged approach includes: Surgery for trichiasis, Antibiotics,
particularly mass treatment with azithromycin of all residents of
endemic districts, Facial cleanliness, and Environmental improve-
ment (Taylor et al., 2012).
Elimination of trachoma as a public health problem has a deﬁni-
tion with two component goals. The ﬁrst is to reduce the prevalence
∗ Corresponding author.
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of trachomatous inﬂammation- follicular (TF) in children 1–9 years
old to <5% at the district level by 2020. The second is to reduce the
prevalence of trachomatous trichiasis cases to <1/1000 at the dis-
trict level. In this article we  focus on the achievement of the ﬁrst
goal outlined.
Mathematical and statistical modelling continues to be used
for a wide range of infectious diseases, including trachoma (Gebre
et al., 2012; Lietman et al., 2011; Liu et al., 2013; Gambhir et al.,
2009; Blake et al., 2009; Pinsent et al., 2016a). Studies are con-
ducted to help understand and quantify epidemiological outcomes
following clinical trials, and to assess the impact of different treat-
ment interventions. In trachoma, detailed randomised control trial
(RCT) data have been analysed and modelled with statistical and
dynamic models (Lietman et al., 2011; Liu et al., 2013; Liu et al.,
2015a; Lietman et al., 1999; Liu et al., 2015b) to assess and pre-
dict the outcomes of given interventions. Such models can also
be used to estimate the resource requirements to achieve certain
goals, such as elimination or the achievement of speciﬁc disease
http://dx.doi.org/10.1016/j.epidem.2017.01.007
1755-4365/© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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prevalence/incidence thresholds (Hollingsworth et al., 2015; Stolk
et al., 2015a; Wouters et al., 2014; Stolk et al., 2015b; Turner et al.,
2016). While producing highly informative and accurate forecasts
for an infectious disease is challenging, it is desirable from a pub-
lic health perspective. This is because they enable high priority
regions to be identiﬁed and help to develop an understanding of
the resources required in different areas in order to achieve the
proposed targets.
Mathematical and statistical models are used to make pre-
dictions about the future prevalence and incidence of infectious
diseases. However, predictions from individual models are not
commonly tested robustly against other potential forecasts, nor
are they regularly validated against independent data. Never-
theless, robust statistical model comparison of outcomes from
different models is essential, in order to understand the limitations
and strengths of different mathematical and statistical modelling
approaches. Most commonly in trachoma, the Susceptible, Infected,
Susceptible (SIS) model structure has been used (Lietman et al.,
2011; Liu et al., 2013; Gambhir et al., 2009; Liu et al., 2015a; Lietman
et al., 1999; Liu et al., 2015b; Ray et al., 2007; Ray et al., 2009),
though variants of this structure have also been proposed (Pinsent
et al., 2016a; Liu et al., 2015b; Shattock et al., 2015). Liu et al. (Liu
et al., 2015a) conducted a statistical model comparison assessing a
variety of statistical and mechanistic models. Fitting each model to
PCR data, the authors found that statistical regression models and
SIS mechanistic models performed signiﬁcantly better than expert
opinion. This suggests that the use of mathematical and statistical
modelling may  be useful in projecting trachoma prevalence (Liu
et al., 2015a).
In this study we compare the probabilistic forecasts of TF
prevalence generated by statistical (without trachoma-speciﬁc
assumptions), mechanistic (SIS and partially acquired immunity)
and mixed (SIS plus a random effect) models to TF prevalence
estimates determined empirically in ﬁeld based surveys, for 9
de-identiﬁed trachoma endemic districts. Probabilistic prevalence
forecasts are scored as the log-likelihood of the observed 2011
data for each district given the model, allowing us to ascertain
the strengths and weaknesses of different modelling approaches
to make forecasts of TF prevalence.
2. Methods
2.1. Data
We  used de-identiﬁed district level TF prevalence data col-
lected and shared by the International Trachoma Initiative (ITI).
These data contained district level TF prevalence at 1 or more time
points, collected between the years 1995–2010. Data after 2010
were available; however, all forecasters were masked to it. Within
this dataset, information regarding the number of rounds of MDA
provided and the years in which they were administered were also
provided for each district. Three of the 4 models we evaluated
used country-level parameters or random effects. These param-
eters were estimated from the ITI data collected between 2001
and 2010. These were data from 43 countries which included 1037
unique districts, of which: 953 had a single survey, 82 had 2 surveys,
1 had 3 surveys, and 1 had 4 surveys.
To estimate the district-level random effects for the SIS and sta-
tistical regression models all district-level data in the ITI database
collected between 1995 and 2010 was used. This included data on
1107 unique districts, of which: 918 had a single survey, 171 had
2 surveys, 17 had 3 surveys, and 1 had 4 surveys; 189 unique dis-
tricts with at least 2 surveys were used to estimate the district-level
random effects.
The district-level transmission coefﬁcients for the deterministic
transmission model used a total of 9 districts for which TF preva-
lence data were present for at least two time points between 1995
and 2010, and for which a TF prevalence data point was  also avail-
able for 2011. As the data were de-identiﬁed by country and district
it was not possible to know the population size of the district at
each sampling time point. For each of the 9 districts we  then fore-
cast the distribution of TF prevalence in 2011. Trends in prevalence
over time for each district are presented in Fig. 1, where each line
represents a separate district. Across 8/9 districts we observed a
gradual decline in TF prevalence following initiation of antibiotic
treatment. We note, that for all districts follow-up was infrequent
and hence we have used a much smaller subset of the data to ﬁt
the models. Data on TF prevalence and years they are reported for
is presented in Table 1.
2.2. Mathematical models
2.2.1. Model 1: deterministic transmission model
The ﬁrst type of model evaluated was an age-structured deter-
ministic ordinary differential equation (ODE) transmission model.
We used a model structure that has been statistically chosen
(Pinsent and Gambhir, 2017) as the most appropriate and parsimo-
nious when ﬁtting to cross-sectional PCR and TF prevalence data
(West et al., 2005). We  consider individuals as susceptible to infec-
tion (S), exposed and incubating (E), infected and infectious with
detectable TF (AI) and those who  remain diseased but no longer
infectious to others (D), individuals in the D state are susceptible
to re-infection with a reduced probability. Those who were re-
infected then returned to the AI state. We  hereafter refer to this
model as Model 1. A schematic diagram of this model structure is
presented in Fig. S1.
The model followed a previously-detailed ‘ladder of infection’
structure (Gambhir et al., 2009; Pinsent et al., 2016a; Pinsent et al.,
2016c), which accounted for the development of immunity to infec-
tion through successive infections (immunity here was represented
as a reduction in an individual’s infectivity and a faster rate of recov-
ery from infection and disease with each successive infection). We
assumed that both the infectivity and that the duration of infection
and disease decreased exponentially with each successive infec-
tion. Further detail on the model structure and parameters used
are provided in the supplementary information and Table S1.
For each of the 9 districts we performed a Markov Chain Monte
Carlo (MCMC) search of the 2D parameter space to estimate and
explore the uncertainty in both estimated parameters (MDA  cover-
age and ˇ). We  then sampled 100 pairs of values from the posterior
distribution to explore the inherent uncertainty in the 2011 fore-
cast generated. Additionally, we  also took 100 sets of samples from
the posterior distributions when our model was  ﬁtted to cross-
sectional PCR and TF data (West et al., 2005) which estimated the
minimum rate of recovery from an individual’s ﬁrst infection and
disease episode. Forecasts of the 2011 prevalence were thus gen-
erated incorporating uncertainty in the minimum rate of recovery
from infection and disease as well as variation in the estimated
value of  ˇ and coverage. This was done to ensure that we explored
the uncertainty in the natural history parameters and how these
uncertainties may  impact the 2011 forecast. All calculations were
performed in the R 3.2.1 (R Core Team, 2015), the package deSolve
was used to solve the differential equation model (Soetaert et al.,
2010).
2.2.2. Model 2: mixed mechanistic and statistical model
We  also assessed a mixed-effect SIS model, of which there were
three different types, hereafter referred to as Models 2.1, 2.2 and
2.3 respectively. 2.1) a model with country-district-level random
effect given all-district data, 2.2) a model with country-district-
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Fig. 1. District level TF prevalence in each of the 9 districts between 1997 and 2010. Every set of two data points and one line indicates the prevalence data for that district.
The  red dashed like indicates the forecasted year of 2011.
Table 1
Data on TF prevalence and the years the data was collected from the 9 anonymised districts evaluated in the study.
District Sample date year 1 Sample prevalence year 1 (%) Sample date year 2 Sample prevalence year 2 (%) Sample date year 3 Sample prevalence year 3 (%)
1 1997 22.7 2007 15.7 2011 0.1
2  1997 3.3 2007 16.4 2011 1.2
3  1997 49.7 2005 11 2011 3.7
4  1999 45.7 2007 33.3 2011 12.8
5  1999 45.7 2007 28.4 2011 10.5
6  1999 27.7 2010 10.5 2011 4.5
7  2004 25.5 2007 13.5 2011 8.3
8  2004 28.0 2007 14.8 2011 11.9
9  2007 40.7 2010 20.2 2011 12.5
level random effect given 9-district data, and 2.3) a model with
country-district-level random effect and treatment given 9-district
data.
2.1) To ﬁt the SIS model with country-level and district-level
random effects given all-district data: for each district, we used the
ﬁrst available year’s data (between 1995 and 2010) from that dis-
trict as the initial prevalence, and predicted the prevalence in each
year (until 2010), and then obtained the likelihood of the data in
the rest of the available years for that district; the total likelihood
was obtained from all districts’ likelihoods. The model’s parameters
were estimated using MCMC  (details on the calculation of the like-
lihood are provided in the supplementary material). To include the
country-level and district-level random effects, we  assumed that
the prior of the transmission coefﬁcient was the same for every
country; the posterior of transmission coefﬁcient within a country
was obtained by weighting with the likelihood of data from that
country. The prior of the transmission coefﬁcient in each district
of a country was the same and from that country’s posterior; the
posterior of the transmission coefﬁcient in a district of that coun-
try was obtained by weighting with the likelihood of data from that
district. With the posterior of the transmission coefﬁcient in each
district, we forecasted TF prevalence in each of the 9 districts in
2011.
2.2) The SIS model with country-level and district-level random
effects given 9-district data, was similar to the ﬁrst model; we used
the 9-district data instead of all-district data to ﬁt the model. For
Models 2.1 and 2.2 a parameter for treatment was not explicitly
modelled and, instead, the effects of treatment were assumed to be
captured by the transmission coefﬁcient parameter. Through this
parameter we capture variation in prevalence through time, thus
indirectly accounting for antibiotic treatment.
2.3) The SIS model with two-level random effects: a country
level random effect and a district level random effect, and treat-
ment (given 9-district data) was  similar to the second model. We
used an efﬁcacy parameter to represent treatment. Prediction by
SIS model was based on the initial prevalence with the treatment
efﬁcacy included. To model the implementation of treatment, we
assumed that, for a given year, a district received treatment if TF
prevalence data was reported in the same year for that district, oth-
erwise we assumed no treatment was  given to that district in that
year as the prevalence point was  only a follow-up survey.
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Table  2
The log-likelihood (LL) score for each model and each district evaluated for both scoring methods applied is provided. We also present the total LL score for each model across
the  total 9 districts analysed. We present within each row for each model the values derived from the ﬁrst scoring method (with 101 bins).
Model type District 1 LL
score*
District 2 LL
score*
District 3 LL
score*
District 4 LL
score*
District 5 LL
score*
District 6 LL
score*
District 7 LL
score*
District 8 LL
score*
District 9 LL
score*
Total LL
score*
Model 1 −3.912 −2.040 −29.933 −2.659 −1.660 −3.506 −2.659 −2.813 −2.659 −51.84
Model  2.1 −4.105 −4.277 −2.397 −3.342 −3.502 −0.881 −3.181 −3.192 −3.343 −28.23
Model  2.2 −3.129 −3.175 −2.950 −3.097 −3.100 −1.911 −3.073 −3.078 −3.100 −26.61
Model  2.3 −2.115 −2.176 −2.592 −3.137 −3.132 −1.336 −2.951 −3.261 −3.268 −23.43
Model  3.1 −2.321 −2.321 −2.653 −3.634 −3.456 −2.321 −3.188 −3.545 −3.634 −27.08
Model  3.2 −2.000 −2.000 −2.627 −3.801 −3.633 −2.005 −3.364 −3.718 −3.801 −26.96
Model  4 −3.122 −2.743 −2.198 3.450 −3.320 −3.673 −2.990 −3.458 −3.348 −28.31
We  modelled treatment for a district in a given year according to
pi =
N∑
i′=i
p(pre)
i′
(
i′
i
)
(1 − ef )ief i′−i, where i’ is the number of infected
people with probability p(pre)
i′ before treatment, i is the number of
infected people after treatment, ef is the product of treatment efﬁ-
cacy and coverage (ﬁxed value assumed), and N is the population
size of the district. To simplify the computation N = 100 in each
district was assumed. Parameters for the SIS mixed-effects model
are presented in Table S2. All calculations were performed in the R
programming language (R Core Team, 2015).
2.2.3. Model 3: district-agnostic statistical forecasts
A single forecast distribution was used for all 9 districts. This dis-
tribution was determined in two ways. In the ﬁrst, the 2-parameter,
zero-inﬂated exponential distribution that had the highest likeli-
hood of the observed district-level prevalence data for each year
from 2001 to 2010 was found. Here we estimated the scale param-
eter and the proportion of districts with a prevalence of zero. A
linear regression on these parameters for each year was  then used
to extrapolate the 2 parameters for the 2011 zero-inﬂated expo-
nential. The single forecast for all 9 districts was thus made from a
2-parameter model. In the second, the 3-parameter, zero-inﬂated
gamma  distribution that had the highest likelihood of the observed
district-level prevalence data for each year from 2001 to 2010 was
found. Here we estimated the shape and scale parameters in addi-
tion to the proportion of communities with a prevalence of zero.
A linear regression on these parameters for each year was used to
extrapolate parameters for the 2011 zero-inﬂated gamma  distri-
bution. The single forecast for all 9 districts was thus made from a
3-parameter model. All calculations were performed in Mathemat-
ica 11.2 (Wolfram Research, Champaign, Illinois). These models are
hereafter referred to as Model 3.1 and 3.2.
2.2.4. Model 4: district-speciﬁc statistical forecasts
A mixed effects regression model was used on log-transformed
data from before 2011. Covariates included district-level clini-
cal activity (TF or TF/TI), survey type (prevalence survey, school
survey, or trachoma rapid assessment), and year, with normally
distributed random intercepts at the country and region level. This
model did not incorporate any understanding of the natural his-
tory of infection. District-speciﬁc forecasts were then made from
this 5-parameter model. All calculations were performed in the R
programming language (R Core Team, 2015) using the package lmer
(Bates et al., 2015). Uncertainty analysis was conducted using the
Metropolis algorithm. This model is hereafter referred to as Model
4.
2.2.5. Scoring
To evaluate the performance of each model’s probabilistic fore-
cast, in comparison to the data, we calculated the log-likelihood
(LL), also known as the Ignorance Score (Good, 1952; Carney and
Cunningham, 2006). Our pre-speciﬁed score was the LL of the
observed 2011 TF prevalence data at the district level. This score
was calculated as the logarithm of the likelihood of the observed
data given the model.
We  calculated the score for each individual district level fore-
cast with two different approaches. The forecasts (calculated as%
prevalence of TF) and the observed data were binned into 101
units for the ﬁrst scoring approach, with the bins delineated by the
[0,0.5), [0.5,1.5), [1.5,2.5), . . .,  [99.5, 100]. For the second scoring
approach the data and forecasts were binned as: [0.5,1.5), [1.5,2.5),
. . .,  [99.5, 100]. The rationale for doing both was  that a high num-
ber of districts worldwide are known to be zero or near zero, and
are therefore not being surveyed. If we  had universal surveying in
our data, the [0,0.5) bin would be very high, and conditioning our
forecast distribution on being greater than 0 may  be more relevant.
As 3 of the 9 districts evaluated had a very low prevalence in 2011
but 6 did not, we  present the scores from both calculations.
Calculation of the LL for each model forecast for each district
was as follows. For each bin for a single district we had a data (TF
prevalence) value for that bin (0 if the data was not in that particular
bin, and 1 if the data was in that bin) and we also had each models
forecasted prevalence distribution within that bin for that district.
Therefore, to obtain the LL for each bin for a single model, for a
single district, we  calculated the following LL = data*LN(forecasted),
where data was  0 for all bins, except the one bin that the data falls
into, which was 1. Forecasted values were between 0 and 1 (and the
total of all the values from all the bins for a district forecast equals
1.000000). Then for the individual district for each model forecast,
we summed the LL values across all bins, to obtain the LL Score for
that district. All calculations were performed using Microsoft Excel.
We calculate p-values using the Wilcoxon signed-rank test for
the comparison between different models using the ﬁrst scoring
method only, as this approach includes the score from all 9 districts
and the second approach only includes 6 districts.
3. Results
The best performing model across all 9 districts (as assessed by
the highest calculated LL score) was  the SIS model with country-
district-level random effects and treatment, given 9-district data
(Model 2.3, Table 2). All model forecasts across the 9 districts are
presented in Fig. 2. This result was  consistent across both scoring
methods (Tables 2 and S3). It was  followed very closely by Model
3, where the gamma  distribution (Model 3.2) was  slightly better
performing than the exponential model. However, the results from
Model 3 were statistically indistinguishable from one another in
terms of their LL scores −27.08 and −26.96 for each model respec-
tively (p = 0.77, Table 2). The next best performing model was Model
4, the mixed-effects regression model. We  note that for models
2–4 the overall LL scores were not signiﬁcantly different from one
another. Comparing Model 2.3 vs Model 2.2, p = 0.31, Model 2.3 vs
Model 4, p = 0.17 and Model 2.3 vs Model 3.1, p = 0.06. The least
well performing model (highest LL score), across all 9 districts
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Fig. 2. Forecast distributions of TF prevalence in 2011 for each of the 9 districts evaluated and for each of the 7 models analysed. Results from model forecasts are shown by
a  solid line and the true data for 2011 for each district is shown with a black dashed line. The colour of each line represents a different model as indicated in the legend.
collectively, was Model 1, with a LL score of −51.84 (Table 1),
markedly worse than the other three models.
Evaluating the performance of each model at the individual dis-
trict level, we saw that for Models 2–4, the value of the LL was
rarely less than −3.5, suggesting a consistent performance at the
individual district level (Table 1). However, these models only very
rarely achieved extremely high LL values, highlighting that while
they were able to predict the data well, their concentration of prob-
ability mass was usually not in the same bin as the actual data. For
Model 1 there was slightly more heterogeneity in the LL scores
between districts (Table 1), with the worst performance seen in
district 3. In districts 2, 4–9 the LL scores were relatively low (all
>-3.5, Table 1), with the LL score of >-3.9 for district 1. Indicating
that for the majority of districts the performance of Model 1 was
comparable to Models 2–4. However for district 3 using Model 1,
the LL score was −29.93 (Table 1). This district began at a very high
initial TF prevalence and declined substantially over the interven-
tion period. As such, the dramatic declines in prevalence observed
in this district could not be captured with Model 1.
Assessing the density distributions for each district for all mod-
els (Table 2, Fig. 2), Model 1 consistently produced the narrowest
TF prevalence forecast (also the least smooth, due to the use of only
100 replicates). Model 1, 2 and 4 resulted in different projections
across each of the different districts. While Model 3.1 and 3.2 pro-
vided the same forecast across all districts (Table 2, Fig. 2) and in
general, the peak of all forecast distributions from these models was
towards zero (Table 2, Fig. 2). Models 2–4 forecast a wider distri-
bution of TF prevalence values, in comparison to the more narrow
forecasts of Model 1. Assessing the ﬁndings in Table 3, for districts
1–3, Models 2.3–4 all had a high probability mass (>0.25) between
the forecasted TF prevalence of: 0–4.9, 5.0–<9.9% and 10.0–< 29.9%
(Table 3). Suggesting that all TF prevalence outcomes were almost
equally likely. This wide variation in forecasted TF prevalence was
consistent for these models across all districts (Table 2 and Table 3),
but to a slightly lesser extent for Model 4. For districts 1–3 the data
indicated no intervention was required, therefore at least 50% of
the time Models 2.3-4 would have substantially over-estimated the
possible intervention effort required. In comparison, for district 5,
>0.70 of the probability mass of Model 1 and 2.1 fell within the range
of the observed data (Table 3) and would have correctly estimated
the additional level of intervention required in the district.
4. Discussion
In this study we  have provided long-term probabilistic fore-
casts of TF prevalence from longitudinal surveillance data across
multiple endemic districts (Liu et al., 2015b), and compared our
ﬁndings across a variety of different mathematical and statistical
models. Overall the SIS model with country-district-level ran-
dom effects and treatment (Model 2.3) was the best performing
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Table  3
For each model and district we present that probability mass of forecasted TF prevalence, which fell within the intervals closest to the ITI programmatic thresholds for
intervention. * indicates that the true data fell within this interval.
Model type District evaluated
District 1 District 2 District 3 District 4 District 5 District 6 District 7 District 8 District 9
Model 1
0–4.9% 0.18 * 0.56 * 0.04 * <0.001 <0.02 0.48 0.20 0.05 0.02
4.5–9.9% 0.54 0.43 0.05 0.51 0.37 0.35* 0.40 * 0.15 0.40
10.0–29.9% 0.28 0.01 0.91 0.48 * 0.61* 0.16 0.40 0.73 * 0.58 *
30.0–49.9% <0.001 <0.001 <0.001 0.01 <0.001 0.01 <0.001 0.07 <0.001
50%+  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Model 2.1
0–4.9% 0.07 * 0.06 * 0.50 * 0.05 0.05 0.84 0.15 0.09 0.06
4.5–9.9% 0.12 0.10 0.24 0.10 0.10 0.13 * 0.18 * 0.15 0.10
10.0–29.9% 0.71 0.72 0.26 0.72 * 0.72 * 0.03 0.60 0.68 * 0.73 *
30.0–49.9% 0.10 0.12 <0.001 0.11 0.11 <0.001 0.07 0.08 0.11
50%+  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Model 2.2
0–4.9% 0.15 * 0.15 * 0.28 * 0.14 0.14 0.38 0.19 0.18 0.14
4.5–9.9% 0.20 0.20 0.26 0.20 0.20 0.28 * 0.23 * 0.22 0.20
10.0–29.9% 0.60 0.60 0.40 0.61 * 0.61 * 0.28 0.54 0.57* 0.61 *
30.0–49.9% 0.05 0.05 0.02 0.05 0.06 0.06 0.04 0.03 0.05
50%+  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Model 2.3
0–4.9% 0.38 * 0.38 * 0.48 * 0.25 0.36 0.65 0.41 0.39 0.51
4.5–9.9% 0.27 0.27 0.27 0.24 0.27 0.22 * 0.27 * 0.27 0.26
10.0–29.9% 0.35 0.35 0.25 0.50 * 0.37 * 0.12 0.32 0.34 * 0.23 *
30.0–49.9% <0.001 <0.001 <0.001 0.01 <0.001 0.01 <0.001 <0.001 <0.001
50%+  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Model 3.1
0–4.9% 0.39 * 0.39 * 0.39 * 0.39 0.39 0.39 0.39 0.39 0.39
4.5–9.9% 0.22 0.22 0.22 0.22 0.22 0.22* 0.22* 0.22 0.22
10.0–29.9% 0.32 0.32 0.32 0.32* 0.32* 0.32 0.32 0.32* 0.32*
30.0–49.9% 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07
50%+  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Model 3.2
0–4.9% 0.40 * 0.40 * 0.40 * 0.40 0.40 0.40 0.40 0.40 0.40
4.5–9.9% 0.22 0.22 0.22 0.22 0.22 0.22* 0.22* 0.22 0.22
10.0–29.9% 0.32 0.32 0.32 0.32* 0.32* 0.32 0.32 0.32* 0.32*
30.0–49.9% 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06
50%+  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Model 4
0–4.9% 0.41* 0.50 * 0.50 * 0.16 0.20 0.37 0.35 0.31 0.06
4.5–9.9% 0.24 0.23 0.23 0.20 0.21 0.26 * 0.26 * 0.25 0.15
10.0–29.9% 0.28 0.22 0.22 0.43 * 0.41 * 0.31 0.33 0.36 * 0.50 *
30.0–49.9% 0.07 0.05 0.05 0.15 0.13 0.05 0.05 0.06 0.23
50%+  <0.001 <0.001 <0.001 0.06 0.05 0.01 0.01 0.02 0.07
model, although the projected uncertainty covered a large range
of prevalence values. However, Model 2.3 was not signiﬁcantly
better than the district-speciﬁc mixed-effects regression model
or the non-district-speciﬁc overall distribution (Models 3 or 4).
The deterministic transmission model (Model 1) had the low-
est total log-likelihood score across all 9 districts; however, it
produced results for 8 out of 9 districts that were close to the
better performing models. Therefore, overall forecasts that utilized
district-speciﬁc information (Models 1 and 2) did not perform sta-
tistically better than the district-agnostic Model 3. The duration
of our projected forecasts ranged between 1 and 6 years, allowing
us to study our models’ ability to capture long-term trends in TF
prevalence. For models 2–4, performance was not impacted by the
duration of the forecast (Table 2 and 3). However, for Model 1 the
forecast for district 3 was the worst performing, and it was  this
district that required the longest forecast duration. Suggesting that
the long duration of the forecast may  have impacted this model’s
performance.
Our forecasts have been made at the district level, and there-
fore pertain directly to assessing the goal of reducing TF prevalence
in children 1–9 to <5% in all endemic districts by 2020. Across all
9 districts we  identiﬁed sustained declines in TF prevalence fol-
lowing MDA. Indeed, for 4 out of 9 districts TF was  below 5% in
2011 and, for 5 out of 9 (which had higher starting prevalence of
TF), TF had still declined. Therefore this study forecasting district
level TF prevalence (although at times with large uncertainty) is the
ﬁrst step towards making statements about likelihood and time to
elimination with regard to the WHO  GET2020 goals.
For the majority of districts Model 1 performed comparably well
to Models 2–4; however, it struggled to predict low prevalence’s,
particularly when the initial reported TF prevalence was very
high. It is challenging to ﬁt deterministic models to low incidence
settings. However, it would be possible to include a non-linear
transmission term to help overcome this issue as it would slow the
dynamics down near a breakpoint and also allow for elimination
(Lietman et al., 2011). Alternatively, MDA  is only one component of
the SAFE strategy, therefore it could be that transmission reduction
measures through F and E have also helped to reduce prevalence
in high transmission settings (Pinsent et al., 2016b). However, cur-
rently no data are available to us on the implementation of F and E
within these districts.
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Models 2–4 were able to perform consistently well across all
districts, as evaluated by the high LL score, even though the uncer-
tainty associated with each forecast resulted in a much wider
expected distribution of TF prevalence values. For Model 2 the abso-
lute range of the forecast was ∼45%, and slightly higher for Models 3
and 4 (Fig. 2). Most commonly, when forecasts are made, how close
the point estimate of the data is to the highest probability mass of
the forecast is the most important outcome. However, when fore-
casting the effect/impact of an intervention or allocating resource
optimally, the uncertainty associated with the outcome can also
be important. If there is large uncertainty surrounding the possible
impact of a given intervention, from a programmatic perspective
we may  apprehensive about investing in the intervention. Indeed,
we observed that with some forecasts we would have substantially
overestimated the effort required to reach TF <5% in some districts
where TF was already <5%, particularly with Models 1, 2.1 and 2.2
(Table 2). However, for a number of districts which showed TF <5%
in 2011 Models 3.1, 3.2 and 2.3 underestimated the additional level
of intervention that would be required. This suggests that such
models may  not be as helpful in districts where prevalence of TF
remains >5%. These models had a wide forecast of TF prevalence,
suggesting that TF <5%–29.5% were almost equally likely.
The scoring metric used here was the LL of the forecast distri-
bution (also known as the ignorance score). The LL of the observed
data fulﬁls the requirements of a proper score, including that if
the forecast coincided with the observations themselves, the opti-
mal  score would be achieved (Bröcker and Smith, 2007). However,
the LL score is a negatively orientated score; which means that
it weights results that have only a low forecast probability heav-
ily. Additionally, this approach evaluates density estimates solely
based on the probability density at the true observation point, and
does not take the calibration of the forecast into account (Soetaert
et al., 2010). The LL score is just one of several proper scores that
could be used. An alternative scoring approach may  be a quadratic
score which would not penalize poor single forecasts as severely,
in comparison to the approach used here.
Across all models there is room for improvement to enhance the
performance of future forecasts. Our models represent a simpliﬁ-
cation of a complex and dynamic biological process. Therefore, it is
possible that some components of the system are missing within
the existing modelling frameworks, and these could be incor-
porated in further work. For example, transmission may  reduce
over time as a consequence of environmental or socio-economic
improvements; however, this has not been considered in any of
the models evaluated here, and could be incorporated with a time
varying transmission parameter, instead of the ﬁxed value used
here. Equally, for the district-agnostic forecasts, alternative distri-
butions could be tested with this data, such as the beta distribution.
Limited data exist to validate the assumed levels of treatment cov-
erage in the model, therefore it is also possible that these estimates
could be improved. Evidence has suggested that antibiotic treat-
ment with azithromycin can have an anti-inﬂammatory effect, and
thus may  reduce TF. This has not may  been explicitly modelled and
inclusion of this may  help to improve Model 1′s forecasts. Addition-
ally, while we have used the best available data on global trachoma
prevalence, the data could be considered sparse in terms of the fre-
quency of follow-up as we  are only forecasting from two  previous
prevalence points. Therefore more frequent follow-up surveillance
data prior to the forecasted time point may  help us understand the
dynamics of disease better. Nevertheless, while it is tempting to
assume that additional data would improve our forecasts, it should
be noted that apparently similar neighbouring communities often
have markedly different prevalence, and that the prevalence in the
same community over time can vary considerably. Thus, additional
data may  only complicate forecasting further.
It is important to note that the data used here were collected
through a number of heterogeneous survey approaches. In addi-
tion, there is also variation in the TF grader training methodologies.
While we acknowledge this limitation of the data it was  not pos-
sible to quantify or account for biases in that data that may  be
present due to this heterogeneity. Such variation may  have resulted
in inconsistencies in the wider dataset that could not be accounted
for. Nevertheless, in the future, as a result of greater international
standardization in both of these things, we will have more reliable
data on which we can base predictive models.
We have demonstrated a statistical model comparison scheme
that allows a range of mathematical and statistical models to be
evaluated and compared. As a next step we  would look to fore-
cast multiple time points for which frequent follow-up data are
available, in order to provide further validation for our models.
However, it may  be that larger datasets with more districts and fre-
quent longitudinal follow-up will be required if we wish to be able
to statistically distinguish the performance of different modelling
approaches. Nevertheless, our results provide hope that different
mathematical models can be used to forecast trachoma successfully
in the future.
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